Should You Buy Diebold Nixdorf, Incorporated Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Diebold Nixdorf, Incorporated (DBD) scores a robust 7.7/10 on our 32-signal Quality of Company framework. At the current market price of $64.22 and a $2.2B market cap, our analysis maps this fundamental strength against 13 institutional-grade models to determine if a sufficient margin of safety exists.
The short answer: 6 of 11 CirclFi valuation models project upside for Diebold Nixdorf, Incorporated (DBD) at $64.22 — the model consensus leans bullish, with a Quality Score of 7.7/10 and Value-Trap risk of 12/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Diebold Nixdorf, Incorporated (DBD) in 2026?
What Is the Bull Case vs the Bear Case for Diebold Nixdorf, Incorporated (DBD)?
| Bull case — $335.55 target (+422.5%) | Bear case — $10.61 target (-83.5%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, Diebold Nixdorf, Incorporated's score of 7.7/10 reflects durable competitive advantages that should sustain earnings power through market cycles. | According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model sees the stock as overvalued with a fair value of $10.61 (-83.5%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the stock shows multi-model upside with a median implied return of +16.8% across 6 bullish models from the current price of $64.22. | According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +506.0% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. |
| According to the CirclFi Deep Alpha Valuation Engine, the First Chicago model targets a fair value of $335.55 (+422.5%), anchoring the bull case with a methodology that evaluates base, bull, and bear scenarios simultaneously. | Industry headwind: valuation multiple compression represents a meaningful risk for Diebold Nixdorf, Incorporated and its Software - Application peers. |
| Industry tailwind: total addressable market (TAM) expansion could provide meaningful support for Diebold Nixdorf, Incorporated's revenue and margin trajectory in the Software - Application space. |
How Does DBD Compare to Its Software - Application Peers?
Valuation data pages: MAPS · VTSI · RBBN · CCC · PDFS · EVCM · MSTR · HSTA · YMM · ADSK · PTC
Which Other Stocks Score Like DBD on Quality?
Closest companies to DBD’s Quality of Company score of 7.7/10, across all industries.
- VLY — Valley National Bancorp (QOC 7.7) · analysis
- SPFX — Standard Premium Finance Holdings, Inc. (QOC 7.7) · analysis
- HMN — Horace Mann Educators Corporation (QOC 7.7) · analysis
- PFBX — Peoples Financial Corporation (QOC 7.7) · analysis
- TTWO — Take-Two Interactive Software, Inc. (QOC 7.7) · analysis
- ARCB — ArcBest Corporation (QOC 7.7) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Software - Application Screens Does DBD Appear In?
So Is Diebold Nixdorf, Incorporated (DBD) Worth Buying in 2026?
Diebold Nixdorf, Incorporated at $64.22 is a genuine coin-flip in our framework. The 6–5 bull-bear split across 11 models, +506.0% model spread, and median fair value of $75.01 (+16.8% vs price) argue for a watchlist position rather than a high-conviction bet. Quality at 7.7/10 adds some comfort to the mix.
These are quantitative model outputs, not investment recommendations. Diebold Nixdorf, Incorporated's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About DBD Stock?
Should I buy DBD stock right now?
Based on CirclFi's multi-model analysis, 6 of 11 models see upside for DBD at $64.22. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 7.7/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Diebold Nixdorf, Incorporated?
Key risks include: wide model disagreement (3063% spread), signaling high uncertainty; general market and sector-specific risks affecting Software - Application companies. Always diversify and consult a financial advisor.
How does DBD compare to its competitors?
Among Software - Application peers, DBD holds a Quality Score of 7.7/10. Comparable companies include MAPS (QOC 7.7), VTSI (QOC 7.6), RBBN (QOC 7.7). The relative ranking helps investors identify whether DBD offers better fundamental quality than alternatives in the same sector.
Is DBD a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. DBD's Quality Score of 7.7/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy DBD at?
CirclFi does not provide target buy prices or price alerts. However, our 11 active models produce fair value estimates ranging from $10.61 to $335.55. At $64.22, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for DBD.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad